Page 18 - rockefeller vaccination plan
P. 18
Financing Solutions for 2022
The financing gap in 2022 is projected to be even The plan to fund this shortfall must be finalized soon to
larger. Utilizing the ACT-A scenario whereby COVAX facilitate necessary advance procurement and to build
targets for 2021 are met, and 100% of all adults are out delivery modalities highlighted in the first part of
vaccinated by the end of 2022, the total costs per this report. Additional funding to fill a portion of 2022
country grouping are given in the table below. ACT-A funding costs must come from grant support
from sovereigns and other donors in addition to
resources mobilized from domestic sources. However,
starting in 2022, additional funding can come from the
International Monetary Fund’s Special Drawing Rights
(SDRs). As SDRs were not designed with this purpose
in mind, designing and delivering a solution will require
creativity, technical innovation and political leadership.
Projected Costs for 2022 by Country
70 PRGT-ELIGIBLE 92 AMC COUNTRIES 133 LOWER AND MIDDLE
COUNTRIES 17 (BILLION USD) INCOME COUNTRIES
(BILLION USD) (BILLION USD)
VACCINE $ 12 $ 25 $ 34
PROCUREMENT
OTHER $ 8 $ 24 $ 36
TOTAL $ 20 $ 49 $ 70
Includes in country labor costs using mid-range ACT-A estimate
THE ROCKEFELLER FOUNDATION ONE FOR ALL AN UPDATED ACTION PLAN FOR GLOBAL COVID-19 VACCINATION 17